<SEC-DOCUMENT>0001213900-20-020097.txt : 20200804
<SEC-HEADER>0001213900-20-020097.hdr.sgml : 20200804
<ACCEPTANCE-DATETIME>20200804122938
ACCESSION NUMBER:		0001213900-20-020097
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200804
FILED AS OF DATE:		20200804
DATE AS OF CHANGE:		20200804

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Zhongchao Inc.
		CENTRAL INDEX KEY:			0001785566
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-EDUCATIONAL SERVICES [8200]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39229
		FILM NUMBER:		201072191

	BUSINESS ADDRESS:	
		STREET 1:		841 YAN AN MIDDLE ROAD, JING AN DISTRICT
		STREET 2:		NANXI CREATIVE CENTER, SUITE 218
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			200040
		BUSINESS PHONE:		021-32205987

	MAIL ADDRESS:	
		STREET 1:		841 YAN AN MIDDLE ROAD, JING AN DISTRICT
		STREET 2:		NANXI CREATIVE CENTER, SUITE 218
		CITY:			SHANGHAI
		STATE:			F4
		ZIP:			200040
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea124985-6k_zhongchao.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 UNDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the month of August 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>ZHONGCHAO INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Translation of Registrant's name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Nanxi Creative Center, Suite 218</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>841 Yan&rsquo;an Middle Road</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Jing&rsquo;An District, Shanghai, China 200040</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Tel: 021-32205987</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Address of Principal Executive Office)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Form 20-F &#9746; Form 40-F &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">CONTENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On August 4, 2020, Zhongchao
Inc. (the &ldquo;<B>Company</B>&rdquo;) issued a press release announcing the renewal of contract with Johnson &amp; Johnson (China)
Limited (&ldquo;<B>J&amp;J</B>&rdquo;), pursuant to which the Company shall continue to serve as J&amp;J&rsquo;s vendor and partner
in China, extending the long-standing cooperation between the Company and J&amp;J in medical research, medical training and education,
and brand building since 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A copy of this press release
is attached hereto as Exhibit 99.1 and is incorporated by reference herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This report does not constitute
an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction
in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws
of any such state or jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 91%; border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD><FONT STYLE="color: Black">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><A HREF="ea124985ex99-1_zhongchao.htm">Press release dated August 4, 2020.</A></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Zhongchao Inc.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 58%">&nbsp;</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid">/s/ Weiguang Yang</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD ROWSPAN="2">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Weiguang Yang</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Executive Officer</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: August 4, 2020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea124985ex99-1_zhongchao.htm
<DESCRIPTION>PRESS RELEASE DATED AUGUST 4, 2020.
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 46pt; width: 151pt"><FONT STYLE="font-size: 12pt"><B><BR STYLE="clear: both">
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Zhongchao Inc. Renews Contract with Johnson
&amp; Johnson (China) Limited, Extending the Cooperation since 2017</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Shanghai, China, Aug. 4, 2020 /PRNewswire/--
Zhongchao Inc. (NASDAQ: ZCMD) (&ldquo;Zhongchao&rdquo; or the &ldquo;Company&rdquo;), a healthcare services company offering patient
management, online healthcare information, professional training and educational services, today announced the renewal of contract
with Johnson &amp; Johnson (China) Limited (&ldquo;J&amp;J&rdquo;), pursuant to which the Company shall continue to serve as J&amp;J&rsquo;s
vendor and partner in China, extending the long-standing cooperation between the Company and J&amp;J in medical research, medical
training and education, and brand building since 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&ldquo;As a Fortune Global 500 company
and the largest pharma company in world measured by 2019 revenue (Fierce Pharma, April 2020), J&amp;J has a strong presence in
the Chinese market with multiple R&amp;D centers and manufacturing facilities and has developed and introduced a large number of
medical devices, pharmaceutical products and technologies (together, the &ldquo;Products and Technologies&rdquo;) in the Chinese
markets. For example, during the 21 months ended October 2019, Xi&rsquo;An Janssen, a majority owned subsidiary of J&amp;J, was
granted approval of over 22 new drugs or indications in China, covering psychiatry, hematology, solid tumors, immunology, infectious
diseases, diabetes, and pulmonary hypertension, etc. The marketing and promotions of these newly introduced Products and Technologies
create significant opportunities for vendors like Zhongchao,&rdquo; commented Weiguang Yang, Chairman and Chief Executive Officer
of Zhongchao.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&ldquo;We see the Chinese healthcare
market remains in its early stage of development and believe it still has tremendous growth trajectory ahead of it. Through cooperation
and partnership with leading pharmaceutical companies like J&amp;J, Zhongchao is poised to capture its fair share of the growth
in years to come,&rdquo; concluded Mr. Yang.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>About Zhongchao Inc. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Incorporated in 2012 with headquarter offices
in Shanghai and Beijing, China, Zhongchao Inc. is an online provider of healthcare information, professional training and educational
services to healthcare professionals under its &ldquo;MDMOOC&rdquo; platform (www.mdmooc.org) and to the public under its &ldquo;Sunshine
Health Forums&rdquo; platform (www.ygjkclass.com) in China. More information about the Company can be found at its investor relations
website at http://izcmd.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>Safe Harbor Statement</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>This press release contains forward-looking
statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning
plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other
than statements of historical facts. When the Company uses words such as &ldquo;may, &ldquo;will, &ldquo;intend,&rdquo; &ldquo;should,&rdquo;
&ldquo;believe,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;project,&rdquo; &ldquo;estimate&rdquo; or similar
expressions that do not relate solely to historical matters, it is making forward-looking statements.&nbsp;Forward-looking statements
are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially
from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and
risks including, but not limited to, the following:&nbsp; the Company's goals and strategies; the Company's future business development;
product and service demand and acceptance; changes in technology; economic conditions; the growth of the professional training
and educational services market in China and the other international markets the Company plans to serve; reputation and brand;
the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in China
and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other
risks contained in reports filed by the Company with the SEC, the length and severity of the recent coronavirus outbreak, including
its impacts across our business and operations.&nbsp; For these reasons, among others, investors are cautioned not to place undue
reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company&rsquo;s filings
with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward<FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT>looking
statements to reflect events or circumstances that arise after the date hereof. </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>For more information, please contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>At the Company:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Pei Xu, CFO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Email: xupei@mdmooc.org</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Phone: +86 21-3220-5987</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><I>Investor Relations:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Tony Tian, CFA&#9;<BR>
Weitian Group LLC<BR>
Email: ttian@weitianco.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Phone: +1 732-910-9692</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "' ;L# 2(  A$! Q$!_\0
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MZ_C6?IE]J-]JEK:OJ=RBS2JA8S-P"<>M=\<!)PYG(XGC$I<J1[M12*H1%4=
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MM7.?[C?XUT%%3*C"2V X&2)X9"DBE6'4&N6NIS<7+R'H3@>PKU?5=-2^@8J
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M>BQ:EJLUS<PI+!;I]UU!!9N!P?;/Z5I5PM"G!R:V\R*>(K3DHIG0?\+0LO\
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M,;?,F^%G_'WJ/^XG\S7=Z_\ \B]J7_7M)_Z":S?"?A>+P[;S'[0)YYB-[J,
M 9P!^=:6O_\ (O:E_P!>TG_H)KSJ\U.OS1VT.VE!PHV9X&>IKM?AC_R,,_\
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M*YVFG9FZ::N@HHJ"\O+?3[5[FZE6*%/O.W:DE?1#;MJ1:K?)IFE7-Z_2&,L
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M@+8[KT(_+-;M\]+FAO8Q2Y9VD>L^$_"\WAP7/FWGG^=C"J"%7&>?KS6IK_\
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MI%!1139)$B0O(X55&26. * %)"J22 !R2:\2\7Z])KFM2E7/V6$E(5[8'?\
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MM)_W^;_&C_A7WA[_ )]I/^_S?XUU%%'MZO\ ,P]C3_E1R_\ PK[P]_S[2?\
M?YO\:!\/_#P8'[+(<?\ 39O\:ZBBCV]7^9A[&G_*-CC2*)(XU"H@"JHZ "G4
M45D:F/JWA?2M;N$GO;<O*J[0RN5./3BL_P#X5]X>_P"?:3_O\W^-=116BK5(
MJRDS-TH-W:.7_P"%?>'O^?:3_O\ -_C1_P *^\/?\^TG_?YO\:ZBBG[>K_,Q
M>QI_RHYJ'P%X>AE63[&S%3G#RL1^6:Z1$5$5$4*JC  & !2T5,JDI_$[EQA&
M/PH****@HXKQ?HLGG'48$W(PQ*!V/K7(5[&0&!!&0>H-85[X2TV[<NBM QZ^
M6>/RKYO,<EE5J.K0Z[H]C!YDJ<%3J].IYS3E7)SVKN?^$(L\?\?,N?PJC>>#
M+F-2UM,DH'\)&TTLMR!NJI8II173N&.S>U-QPZ;;Z]CEZM6>H75A)OMIF0]P
M.A_"HKBVFM93%/&R..S#%4KVY^RVK2?Q=%'O7Z$HQ:LMCXJ[3OU.J/Q"-DH6
M\@21_1#@_P!:@/Q3BWX&E,4]3-S_ .@UYL[,[EV)+$Y)-)1]2H]4:K%55U/4
M5^)$=W\EO:K%(>@E;/\ A67?ZO>ZBV;B9BO9!P!^%<%TZ=:Z+3+LW5OASF1.
M"?4=C0L-3IZQ1,JTYZ29=K U2S:"<S*/W3G/T/I70QQ/,X2-"S$X  R3706G
M@V\N4S<LD*,/NM\Q_*AU8T]9,F-.4_A1Y=17JK_#'37Y^U3(?]@#'Y'-6;'X
M<:-:RB29I[G'\+L OZ?XU+QU%(V6#JLY#P+X:EU34X[^>,BSMVW9(^^PZ ?U
M_P#KUZ_3(88K>%888UCC0855& !]*?7EUZ[K2YF>A1HJE&P4C'"D^@I:1AE2
M/45@;'F[?$&[&A&7?;?VC]IV>7Y;8\O;UZ]<^]>CJ<H#ZC-<8?  .@G3OMD?
MFFY\_P _R><;<;>OX]:[0#"@>@Q716=)_P /S,**J*_.>?VWBW6+S5I[1+O3
M(-ER8429'W/\V!C&17H-<=;^#]3LKVXGL]:2))IC*R_958]<]2:ZZ57:%UC8
M*Y4A6(S@^M*NX-KDV"BII/F./M/%UU-XO-C)'&-.DE>"&3;R74#/.>>?YBNQ
M<[48CJ!FN,'P^BBM[1X+UDOX)?-:=@2&YS]W/';\J[-AN0KZC%%;V=UR#I>T
ML^<P?"&LW6N:3)<W8C$BS%!Y8P,  _UJYX@N-0M-)EN=-,'FP@R/YP)!0 DX
MQWZ5CZ'X5U/1)46+6LVGF;Y(! !N]><\=*Z2_M?MNGW-KOV>=$T>[&<9&,TI
M\BJ7CJ@ASNG9[F1X3U#5-4TS[;J/V;9+_J1""" "0<Y^@JOXB\22Z)K>FP,T
M26D^3,S*20 >V*U]#TPZ/H]O8&42F('YPN,Y)/3\:IZMX>&J:UI]^TRA+0G,
M3)NW\_6FI4_:MO;7_@":G[-);E?PIK\^NOJ)E,9BAFVPE%(RO.,Y^@KI*Q/#
M^@?V'+?OYZR+=3>8%";=@R>.OO6W45>5S?)L73YN7WMRMJ-P]KIEU<1@%XH7
M=0>F0"16=H=]-?CS'U*WN1Y89HXH=I0GWW'WK2OK;[987-J&V>=$T>[&<9&,
MT^VA^SVL4.=WEH%SCK@8J4URVZC:?-<I:K>SV[6MM:A!<7<OEHSC(0 %F;'?
M@=/6FV%W=+J5QIMXZ2R1QK-'*B[=Z,2.1S@@@_F*FU.P:]6!X9?*N;>3S8G*
MY&<$$$=P02*;86$L-U/>W<R2W4RJGR+M5$7.% ))ZDG\:?N\HO>YB+7;^6PA
MM3%/#!YUP(FEE7*J"K'/4>@[TW1=1FO9;N*26&YC@90ES"NU7R.1U/(]CW%6
M[^Q^VO:$N%$$XE((SNPK#'ZTVQT_[#<7;1N/(GD\U8\?<8CYOP)&?J31>/+;
MJ%I<U^A>J.=97@=89%CD(^5V7< ?ID9J2BH-#&T.?4+HW$EW<PND<TD(1(=I
M)5L9SN/ITJ;6M2.EQ6DNY%C>Y2.1F&<*<Y_E4^G6)L8YT,F_S9Y)LXQC<Q./
MUI-0L#?&UQ)L\BX6;IG=C/'ZU=TY7>Q%GR^95T_64U'5[J"WD22WBAC8,H.=
MQ+9'Z"EU_4)M.LX)(I8XC)<)$TDB[@BGJ<9%68K$QZO<7WF9$L*1[,=-I8YS
M_P "_2F:MI\NH00+#,L4D,Z3*77<"5[$9%.\>9=A6ERON+I4TEQ;&5KV&[4M
M\KQ1[ /;J:OU6LTO$5A>2PR-GY3%&4P/?)-6:B6Y<=BCK-W)8:->7<.WS(8F
M==PR,@=ZH:=JD\NK+9M=VU[&T)E,D"X\H@@8;!(YR<?0UI:G9_VCI=S9A]GG
M1E-V,XR/2IX8(H$VQQH@[[5 S5)I1MU):;D9^OW\NG:<LT,D<9::.,R2+N"A
MF )QD=C4FDS27$#RM?PWB%L*T46P#U'4YI=6L)-0M$CAE6*1)DE5F7<,JP."
M,CTJ6S2]0/\ ;)H)#QM\J,ICZY)HTY/,->8K:E=W*WMII]FR)-<!W:5UW!$7
M&2!W)) I=+O)Y9[RRNRC3VKJ#(@P'5AD''8]0?I3M1T^6YGMKNUF6*ZMRVTN
MNY65ARI&1Z _A2Z;I[VC7$\\HENKEP\KJNU1@8"@>@ _G1[O*+WN8K:UJ$UI
M=6$$=S!;).SAY9ER!A<CN*ET2_EU"UE>4QN8YFB6:($)*!_$/Y=3R#4M[IJ7
MM]97$A4I;ER8V7(;<N/TJZJJBA5 "C@ #I0VN5+J-)\US/\ MLO_  D7V'"^
M3]E\[ISNW8_+%:-95YIUXVK+J%G<PQMY'DE98BP(W9SP16E$'$2"5E:3 W%1
M@$]\"D[:6'&^MSGK75KF[U2XMSJ5K"T=TT26YAW,RCWW=_I725C6^FZC9W%P
M;>[MO(GN&F*O"2PSU&0W]*V:<[=!0OU"BBBH+"BBB@"IJ&FVVI0&*XC!_NL.
MJ_2O)O&.ESZ5)'#)RA<E7'1ABO9*P_%>AC7M$DMT ^T)\\)/]X=OQZ5U86NZ
M<TGL<V(H*<;K<\-HI\T,D$SQ2HR2(<,K#!!IE>[N>0%;OA6RGU#4GMX%R649
M]!SU-80!)P.M>P> O#[Z1I37-RFVZN<':1RB=A_7\JY\565*G?J;4*3J3MT-
MS2M%MM*A 10TQ'S2$<GZ>@K2HHKP92<G=GL1BHJR"BBBD4%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8.N^$=
M,UX^9,ABN,8\Z+@GZ^M<JWPK;>=NJC9GC,'/_H5%%;PQ-6"M%F,Z%.3NT=!H
MG@72]'E6=MUU<+RKR#A3Z@?XYKJ***SG4E-WD[FD(1@K104445!04444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
G %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
